NeoGenomics, Inc. (NEO) Max Pain Analysis

Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.

NeoGenomics, Inc. (NEO) operates in the Healthcare sector, specifically the Medical - Diagnostics & Research industry, with a market capitalization near $215.1M, listed on NASDAQ, employing roughly 2,200 people, carrying a beta of 1.80 to the broader market. NeoGenomics, Inc. Led by Anthony Zook, public since 2004-03-16.

Snapshot as of May 15, 2026.

Spot Price
$8.29
Total OI
11.1K

Learn how max pain is reported and how to read the data →